FundedIQ
Biotechnology

Again: Funding, Investors & Team (Sep 2026)

Again is a company that specializes in turning carbon emissions into useful chemicals. They use advanced methods to capture CO2 emissions from industries and convert them into materials that have commercial value. Again is dedicated to combating climate change by capturing carbon emissions, repurposing them into beneficial products, and promoting sustainable practices in the industrial sector.

again.bio LinkedIn Copenhagen, Denmark 11-50 employees
Biotechnology Chemical Industrial Manufacturing Manufacturing
Total raised
$43.0M
Rounds
1
Latest
Series A
Jul 2024

Again has raised $43.0M across 1 funding round on record, the most recent a Series A of $43.0M announced in Jul 2024.

That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Again Company Profile and Key Stats

Total funding raised
$43.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Series A
$43.0M in Jul 2024
Employees
11-50
reported band
Headquarters
Copenhagen, Denmark

Latest funding round on record: Jul 2024.

Again Funding Rounds

Date
Round
Amount
Series A
$43.0M

Again Founders and Leadership Team

Name
Role
Contact
Jessica Farrow
Founder

No contact details are on record for this team yet.

Again Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,179
$8.0M
371
$3.8M
8,352
$15M

Again's latest round of $43.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Again in Biotechnology and Copenhagen

Companies Similar to Again

Curasight is a biotech company focused on addressing the need for improved diagnosis and treatment of several…

Undisclosed round $3.1M

Alcolase is a Danish life science start-up that specializes in alcohol flushing.

Seed $1.7M

ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on…

Series C $75.0M

ENZIDIA is unleashing the biomanufacturing revolution with an enzyme acceleration revolution

Angel $240k

Gefjon Pharma is a biopharmaceutical company focused on developing innovative solutions to combat…

Seed $1.5M

Synuca Therapeutics focused on developing innovative therapies for neurological disorders, particularly…

Seed $1.5M

Galecto develops small molecules for the treatment of severe diseases, including fibrosis and cancer. The…

Undisclosed round $275M

Pioneering new sustainable bio-based ingredients

Series A $5.9M

Muna Therapeutics is a private biopharmaceutical company that discovers and develops therapies that slow or…

Undisclosed round $1.0M

EvodiaBio is a company in the bio-industrial sector that develops eco-friendly fragrances for the food and…

Undisclosed round $7.1M

Fida Biosystems is a technology that provides the detection and characterization of proteins and…

Series A $5.9M

Chromologics is a company that creates new and original food colorings utilizing natural ingredients. Derived…

Undisclosed round $8.1M

Again Funding FAQs

What does Again do?

Again is a company that specializes in turning carbon emissions into useful chemicals. They use advanced methods to capture CO2 emissions from industries and convert them into materials that have commercial value. Again is dedicated to combating climate change by capturing carbon emissions, repurposing them into beneficial products, and promoting sustainable practices in the industrial sector.

How much funding has Again raised?

Again has raised $43.0M across 1 round on record. The most recent is a Series A of $43.0M announced in Jul 2024.

When did Again last raise funding?

Again's most recent funding round on record is a Series A of $43.0M, announced in Jul 2024.

Who founded Again?

FundedIQ lists Jessica Farrow (Founder) at Again.

Where is Again headquartered?

Again is based in Copenhagen, Hovedstaden, Denmark.

How many employees does Again have?

Again is in the 11-50 employee band.

How does Again's funding compare to other Biotechnology startups?

Again's latest round of $43.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.

About FundedIQ's Again Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Again is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.